{"result": "(\"entity\"<|>ALOPECIA AREATA<|>EVENT<|>Alopecia areata is a condition being studied and treated in various research studies, often involving treatments with minoxidil and compound glycyrrhizin)\n##\n(\"entity\"<|>SCHOOL-AGE CHILDREN<|>PERSON<|>School-age children are a specific group mentioned in the context of a study on the therapeutic effect of compound glycyrrhizin combined with 2% minoxidil solution)\n##\n(\"relationship\"<|>MINOXIDIL<|>ALOPECIA AREATA<|>Minoxidil is used in various studies as a treatment for alopecia areata<|>9)\n##\n(\"relationship\"<|>COMPOUND GLYCYRRHIZIN<|>ALOPECIA AREATA<|>Compound Glycyrrhizin is used in combination with minoxidil for treating alopecia areata<|>9)\n##\n(\"relationship\"<|>SCHOOL-AGE CHILDREN<|>ALOPECIA AREATA<|>A study focused on the therapeutic effect of treatments on school-age children with alopecia areata<|>5)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4-turbo-preview", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: ):114–116. 18. Wang LL. Clinical efficacy observation of 5% minoxidil solution \ncombined with compound glycyrrhizin in the treatment of alo -\npecia areata. Chin J Mod Drug Appl. 2016;10(4):174–175.\n 19. Chen YH. The effect evaluation of minoxidil tincture of joint \ncompound glycyrrhizic on alopecia areata and the influence \non serum TNF-α, TGF-β1 and of IL–12. J Clin Pathol Res. \n2015;35(6):1038–1042.\n 20. Yue Z, Jiang CJ. Observation on the therapeutic effect of \ncompound glycyrrhizin combined with 2% minoxidil solution \nin the treatment of alopecia areata in school-age children. J \nQiqihar Univ Med. 2015;36(27):4104–4105.\n 21. Fu Y, Wei YH, Zhang HR, et  al. Curative effect of treating alo -\npecia areata by compound glycyrrhizin combined with local -\nly applied minoxidil and the influence on serum IFN-γ and \nIL-10. Progr Modern Biomed. 2013;13(28):5498–5501.\n 22. Cao HY. Observation on the therapeutic effect of compound gly -\ncyrrhizin combined with minoxidil tincture in the treatment of \nalopecia areata. Guide China Med. 2012;10(10):484–485.\n 23. Yu Y, Yuan B. Observation on the therapeutic effect of com -\npound glycyrrhizin tablets combined with minoxidil solution \nin the treatment of alopecia areata. Chin J Aesth Med. \n2012;21(10):1784–1785.\n 24. Wu GG. Observation on the therapeutic effect of compound \nglycyrrhizin combined with 5% minoxidil solution in the \ntreatment of 50 cases of alopecia areata. Jiangxi Med J. \n2011;46(10):936–937.\n 25. Li XJ, Wang XX, Liu DF, et  al. 48 cases of alopecia areata treated \nwith compound glycyrrhizin tablets combined with topical 5% \nminoxidil solution. Chin J NewDrug. 2009;18(23):2236–2237.\n 26. Waśkiel-Burnat A, Osińska M, Salińska A, et  al. The role of se -\nrum Th1, Th2, and Th17 cytokines in patients with alopecia \nareata: clinical implications. Cells. 2021;10(12):3397. doi: \n10.3390/cells10123397 .\n 27. Alzolibani AA, Rasheed Z, Bin Saif G, et  al. Altered expression \nof intracellular Toll-like receptors in peripheral blood mono -\nnuclear cells from patients with alopecia areata. BBA Clin. \n2016;5:134–142. doi: 10.1016/j.bbacli.2016.03.006 .\n 28. Omar SI, Hamza AM, Eldabah N, et  al. IFN-α and TNF-α serum \nlevels and their association with disease severity in Egyptian \nchildren and adults with alopecia areata. Int J Dermatol. \n2021;60(11):1397–1404. doi: 10.1111/ijd.15658 .\n 29. Zöller M, McElwee KJ, Vitacolonna M, et  al. The progressive state, \nin contrast to the stable or regressive state of alopecia areata, is \nreflected in peripheral blood mononuclear cells. Exp Dermatol. \n2004;13(7):435–444. doi: 10.1111/j.0906-6705.2004.00179.x .\n 30. Attia EA, El Shennawy D, Sefin A. Serum interleukin-4 and total \nimmunoglobulin E in nonatopic alopecia areata patients and \nHLA-DRB1 typing. Dermatol Res Pract. 2010;2010(1):503587. doi: \n10.1155/2010/503587 .\n 31. Van Acker MM, Schwartz RR, Andrews K, et  al. \nInheritance-specific dysregulation of Th1- and Th17-associated \ncytokines in alopecia areata. Biomolecules. 2023;13(9):1285. \ndoi: 10.3390/biom13091285 .\n 32. Ma X, Chen S, Jin W, et  al. Th1/Th2 PB balance and CD200 \nexpression of patients with active severe alopecia areata. Exp \nTher Med. 2017;13(6):2883–2887. doi: 10.3892/etm.2017.4312 .\n 33. Luk NM, Chiu LS, Lee KC, et  al. Efficacy and safety of di -\nphenylcyclopropenone among Chinese patients with steroid \nresistant and extensive alopecia areata. J Eur Acad Dermatol \nVenereol. 2013;27(3):e400–e405. doi: 10.1111/jdv.12009 .\n 34. Tembhre MK, Sharma VK. T-helper and regulatory T-cell cyto -\nk\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>MINOXIDIL<|>ORGANIZATION<|>Minoxidil is frequently mentioned in the context of treating alopecia areata, indicating its role as a medication or treatment method)\n##\n(\"entity\"<|>COMPOUND GLYCYRRHIZIN<|>ORGANIZATION<|>Compound Glycyrrhizin is combined with minoxidil in various studies to treat alopecia areata, suggesting its medicinal properties)\n##\n(\"entity\"<|>CHIN J MOD DRUG APPL<|>ORGANIZATION<|>A journal where a study on the clinical efficacy of 5% minoxidil solution combined with compound glycyrrhizin was published)\n##\n(\"entity\"<|>J CLIN PATHOL RES<|>ORGANIZATION<|>A journal that published a study on the effect evaluation of minoxidil tincture and compound glycyrrhizic on alopecia areata)\n##\n(\"entity\"<|>J QIQIHAR UNIV MED<|>ORGANIZATION<|>A medical journal that observed the therapeutic effect of compound glycyrrhizin with 2% minoxidil solution on school-age children with alopecia areata)\n##\n(\"entity\"<|>PROGR MODERN BIOMED<|>ORGANIZATION<|>A publication that discussed the curative effect of treating alopecia areata with compound glycyrrhizin and minoxidil)\n##\n(\"entity\"<|>GUIDE CHINA MED<|>ORGANIZATION<|>A medical guide that observed the therapeutic effect of compound glycyrrhizin with minoxidil tincture on alopecia areata)\n##\n(\"entity\"<|>CHIN J AESTH MED<|>ORGANIZATION<|>A journal that observed the therapeutic effect of compound glycyrrhizin tablets with minoxidil solution on alopecia areata)\n##\n(\"entity\"<|>JIANGXI MED J<|>ORGANIZATION<|>A medical journal that observed the therapeutic effect of compound glycyrrhizin with 5% minoxidil solution on alopecia areata)\n##\n(\"entity\"<|>CHIN J NEWDRUG<|>ORGANIZATION<|>A journal that published a study on 48 cases of alopecia areata treated with compound glycyrrhizin tablets and topical 5% minoxidil solution)\n##\n(\"entity\"<|>CELLS<|>ORGANIZATION<|>A scientific journal that published a study on the role of serum Th1, Th2, and Th17 cytokines in patients with alopecia areata)\n##\n(\"entity\"<|>BBA CLIN<|>ORGANIZATION<|>A clinical journal that discussed altered expression of intracellular Toll-like receptors in peripheral blood mononuclear cells from patients with alopecia areata)\n##\n(\"entity\"<|>INT J DERMATOL<|>ORGANIZATION<|>A dermatology journal that published a study on IFN-α and TNF-α serum levels and their association with disease severity in Egyptian children and adults with alopecia areata)\n##\n(\"entity\"<|>EXP DERMATOL<|>ORGANIZATION<|>A dermatological journal that discussed the progressive state of alopecia areata reflected in peripheral blood mononuclear cells)\n##\n(\"entity\"<|>DERMATOL RES PRACT<|>ORGANIZATION<|>A journal that published a study on serum interleukin-4 and total immunoglobulin E in nonatopic alopecia areata patients)\n##\n(\"entity\"<|>BIOMOLECULES<|>ORGANIZATION<|>A scientific journal that discussed inheritance-specific dysregulation of Th1- and Th17-associated cytokines in alopecia areata)\n##\n(\"entity\"<|>EXP THER MED<|>ORGANIZATION<|>A medical journal that published a study on Th1/Th2 PB balance and CD200 expression of patients with active severe alopecia areata)\n##\n(\"entity\"<|>J EUR ACAD DERMATOL VENEREOL<|>ORGANIZATION<|>A journal that discussed the efficacy and safety of diphencyprone among Chinese patients with steroid resistant and extensive alopecia areata)\n##\n(\"relationship\"<|>MINOXIDIL<|>COMPOUND GLYCYRRHIZIN<|>Minoxidil is often combined with Compound Glycyrrhizin in treatments for alopecia areata<|>9)\n<|COMPLETE|>"}]}